PRIMARY OBJECTIVE:~I. To examine the feasibility, acceptability and preliminary efficacy of txt4AML in a pilot single arm study.~SECONDARY OBJECTIVE:~I. To explore the association between overall treatment responses and real-time oral anti-cancer medication (OAM) adherence.~EXPLORATORY OBJECTIVE:~I. To summarize and assess other patient-reported outcomes, collected either as patient chart review or through self-reported survey, as well as the patient post-intervention interviews.~OUTLINE:~Patients receive interactive text messages to help with adherence to medications and a smart pill bottle with medication reminders on study.
This clinical trial studies how well a mobile intervention consisting of a text messaging program and an electronic smart pill bottle with medication reminders works to improve adherence to oral anti-cancer medications among patients with acute myeloid leukemia (AML). Medication adherence is how well patients take medications as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a barrier to effective treatment. Collecting feedback on patient experiences using the mobile intervention may help doctors design new methods and material for providing educational information to AML patients who are taking oral anti-cancer medications.